Products affected have expiration dates ranging from February 2024 to September 2025, according to an FDA notice published Feb. 26.
For patients who use the products, which were recalled following an FDA inspection of the production facility, there is a risk of eye infections or related harm.
The products were distributed by wholesalers, retailers and via Walmart, CVS and AACE Pharmaceuticals.
The last year has been a busy one for eye product recalls, with a recall in March 2023 of eye drops that caused bacterial eye infections, and even death, among users.
Global Pharma Healthcare recalled its Artificial Tears Lubricant Eye Drops, distributed by EzriCare and Delsam Pharma, after they were linked to a rare strain of bacteria that caused dozens of infections and at least eight cases of vision loss, four eye removals and three patient deaths.
For a full list of recalled products, click here.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.